Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tighe Reardon currently holds 633,673 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tighe Reardon has been a net seller of JANX stock. They have purchased $21.7M and sold $45.0M worth of shares.
Tighe Reardon's most recent insider trade was on Jun 3, 2024, when they sold 131,196 shares at $54.75 per share.
Tighe Reardon serves as Executive at Janux Therapeutics, Inc. (JANX). They have executed 11 insider transactions totaling $66.7M over their tenure at the company.
Tighe Reardon holds the position of Executive at Janux Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Tighe Reardon has shown a selling trading pattern, with $21.7M in total purchases and $45.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Tighe Reardon was on Jan 23, 2020, when they sold $114.4M worth of THOR shares. This transaction involved 1,682,086 shares at $68.00 per share.
Tighe Reardon currently owns 633,673 shares of Janux Therapeutics, Inc. (JANX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tighe Reardon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tighe Reardon has 11 Form 4 filings on record as an insider at Janux Therapeutics, Inc..
Set alerts for Tighe Reardon and 40,000+ other insiders.